Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Sep. 30, 2023
Current assets
Cash and cash equivalents	$ 1,045	$ 1,053
Short-term investments	250
Accounts receivable, net	732	834
Deferred costs	150	180
Prepaid expenses and other current assets	385	381
Total current assets	2,562	2,448
Fixed assets	33	30
Goodwill	1,356	1,356
Deferred costs		150
Total assets	3,951	3,984
Current liabilities
Accounts payable and accrued liabilities	729	613
Deferred revenue	515	280
Promissory note payable		50
Income taxes payable	3	11
Total current liabilities	1,247	954
Other liabilities
Total liabilities	1,247	954
Commitments and contingencies (Note 16)
Common stock, $0.001 par value, 681,000,000 shares authorized; 225,975,331 and 213,854,781 shares issued and outstanding as of September 30, 2024, and 2023, respectively	226	214
Additional paid-in capital	22,321	21,755
Accumulated deficit	(19,843)	(18,939)
Total stockholders’ equity	2,704	3,030
Total liabilities and stockholders’ equity	$ 3,951	$ 3,984